Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060304 in Healthy and Elevated LDL-C Subjects
Clinical trial NCT06485245 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06485245
- Sponsor
- Cascade Pharmaceuticals, Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-22
- Primary completion
- 2025-11-20
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.